Related Experiment Videos
Summary
Ureteral carcinoma in situ, found during bladder cancer surgery, rarely impacts patient outcomes. Conservative treatment is likely appropriate for this specific ureteral abnormality.
Area of Science:
- Urology
- Oncology
Background:
- Ureteral carcinoma in situ (CIS) can be incidentally found during cystectomy for bladder cancer.
- The clinical significance and optimal management of incidentally detected ureteral CIS remain areas of investigation.
Purpose of the Study:
- To evaluate the clinical impact of ureteral CIS diagnosed at the time of cystectomy for bladder carcinoma.
- To determine if this finding influences postoperative outcomes and necessitates specific interventions.
Main Methods:
- Retrospective review of patient records.
- Analysis of 30 patients with ureteral CIS or other ureteral abnormalities identified during cystectomy.
- Assessment of postoperative ureteral and upper urinary tract status.
Main Results:
- The incidence of ureteral CIS at cystectomy was 8.7%.
- No significant postoperative ureteral or upper urinary tract issues were observed in 29 of 30 patients with complete follow-up.
- One patient with infiltrating ureteral carcinoma remained well 8 years post-cystectomy.
Conclusions:
- Ureteral CIS diagnosed during cystectomy for bladder cancer appears to have minimal impact on patient prognosis.
- Conservative management strategies are likely suitable for incidentally detected ureteral CIS.
- Further follow-up is needed for patients lost to the study.